We are live on ! Find out more

415 hedge funds and large institutions have $6.38B invested in Chemed in 2019 Q4 according to their latest regulatory filings, with 59 funds opening new positions, 145 increasing their positions, 136 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

228% more call options, than puts

Call options by funds: $14.7M | Put options by funds: $4.48M

119% more first-time investments, than exits

New positions opened: 59 | Existing positions closed: 27

7% more capital invested

Capital invested by funds: $5.94B → $6.38B (+$438M)

6% more funds holding

Funds holding: 393415 (+22)

7% more repeat investments, than reductions

Existing positions increased: 145 | Existing positions reduced: 136

0.06% less ownership

Funds ownership: 90.57%90.52% (-0.06%)

29% less funds holding in top 10

Funds holding in top 10: 75 (-2)

Holders
415
Holders Change
+22
Holders Change %
+5.6%
% of All Funds
8.18%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.1%
New
59
Increased
145
Reduced
136
Closed
27
Calls
$14.7M
Puts
$4.48M
Net Calls
+$10.2M
Net Calls Change
+$9.16M

CHE Hedge Fund Activity: Q4 2019 in Review

415 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Chemed (CHE) for Q4 2019, worth a combined $6.38B — up 7.4% from $5.94B a quarter earlier.

Buyers outnumbered sellers: 59 funds opened new CHE positions and 27 closed out — a net gain of 32 holders — while 145 added to existing stakes and 136 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $30.2M. The largest seller was BlackRock, cutting an estimated $40.3M.

  • 415 institutional investors held Chemed (CHE) as of Q4 2019, up from 393 in Q3 2019.
  • Funds reported $6.38B of Chemed stock for Q4 2019, up 7.4% quarter-over-quarter.
  • 59 funds opened new Chemed positions in Q4 2019 and 27 closed out, a net change of +32 holders.
  • The largest Chemed buyer in Q4 2019 was Fidelity Investments, an estimated $30.2M added.
  • The largest Chemed seller in Q4 2019 was BlackRock, an estimated $40.3M sold.

Based on aggregated 13F filings for Q4 2019.